fig2
Figure 2. The overall survival in patients treated with DAAs after curative treatment for HCC. The survival rates at 1, 2 and 3 years were 99%, 98% and 95%, respectively. HCC: hepatocellular carcinoma; DAA: direct-acting antiviral
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
